Consultant Cornea Services, Clear Vision, 201, Bhavya Plaza, Station Road, Khar (W), Mumbai, India.
Indian J Ophthalmol. 2013 Aug;61(8):433-4. doi: 10.4103/0301-4738.116072.
Corneal collagen cross-linking with riboflavin and UVA light (CXL) is the only method designed to arrest the progression of keratoconus. Visual improvement generally starts 3 months after treatment. Reduction is coma seen on aberrometry in early postoperative phase is also responsible for the improvement in visual acuity. In the light of currently available data we can thus say that CXL is a safe procedure that is successful in arresting keratoconus.
角膜胶原交联术联合核黄素和 UVA 光（CXL）是唯一旨在阻止圆锥角膜进展的方法。视觉改善通常在治疗后 3 个月开始。在早期术后阶段，像差仪上观察到的彗差减少也是视力提高的原因。根据目前可用的数据，我们可以说 CXL 是一种安全有效的治疗圆锥角膜的方法。
